<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01320917</url>
  </required_header>
  <id_info>
    <org_study_id>MIR-01</org_study_id>
    <nct_id>NCT01320917</nct_id>
  </id_info>
  <brief_title>Levonorgestrel-releasing Intrauterine Device on Obese Women: Effects on Hemostatic and Arterial Function</brief_title>
  <official_title>Levonorgestrel-releasing Intrauterine Device Effects on Hemostatic and Arterial Function of Obese Women</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Sao Paulo</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University of Sao Paulo</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Obesity is a disorder associated with metabolic dysfunction and changes in cardiovascular
      risk markers; the use of oral contraceptives (OCs) may exert a further negative effect on
      these alterations in patients with PCOS.

      To assess the effects on arterial function and structure and hemostatic parameters using an
      levonorgestrel intrauterine device (IUS-LNG) in women with obesity

      A randomized controlled clinical trial.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Setting: Academic hospital.

      88 women between 18 and 40 years of age with obesity (BMI between 20 and 40 kg/m2)randomized
      to use IUS-LNG or Copper-IUD for 12 months

      Exclusion criteria: category 3 and 4 Medical Eligibility Criteria for IUD-Cu and IUS-LNG -
      WHO-2010, pregnancy, lactation, concomitant drugs, smoking.

      Main Outcome Measures: Brachial artery flow-mediated vasodilation, carotid intima-media
      thickness and the carotid artery stiffness index were evaluated at baseline and after 6 and
      12 months. Serum markers of cardiovascular disease and hemostatic parameters will be also
      analyzed.
    </textblock>
  </detailed_description>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Active, not recruiting</last_known_status>
  <start_date>February 2009</start_date>
  <completion_date type="Anticipated">September 2011</completion_date>
  <primary_completion_date type="Anticipated">July 2011</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Arterial function and structure</measure>
    <time_frame>6 and 12 months of following</time_frame>
    <description>Brachial artery flow-mediated vasodilation, carotid intima-media thickness and the carotid artery stiffness index</description>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">88</enrollment>
  <condition>Contraception Desired</condition>
  <condition>Obesity</condition>
  <arm_group>
    <arm_group_label>LNG-IUS</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Insertion of a LNG-IUS device</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Cu-IUD</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>Insertion of a Cu-IUD</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Levonorgestrel releasing device</intervention_name>
    <description>LNG-IUD device releases levonorgestrel in circulation</description>
    <arm_group_label>LNG-IUS</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Cu-IUD insertion</intervention_name>
    <description>The action of a Cu-IUD does not release any hormonal compound</description>
    <arm_group_label>Cu-IUD</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Women 18 to 40 years of age with obesity grade I and II who wished to use a
             contraceptive

        Exclusion Criteria:

          -  any clinical conditions corresponding to category 3 or 4 of the World Health
             Organization medical eligibility criteria for IUD-LNG or IUD-CU use smoking

          -  alcoholism

          -  illicit drug use

          -  any systemic disease (systemic arterial hypertension, DM, immune system diseases or
             thyroid diseases) except PCOS

          -  current or previous (up to two months before the study) use of oral, vaginal, monthly
             injectable or transdermal combined hormonal contraceptives current or previous use (up
             to six months before the study) of a long-lasting hormonal contraceptive method
             (injectable, implant or intrauterine device)

          -  twelve weeks or less since childbirth

          -  currently breastfeeding or had stopped breastfeeding within two months of the
             screening visit

          -  chronic and/or acute inflammatory processes

          -  use of drugs known to interfere with inflammatory markers or with CVD risk
             (anti-androgens, hypoglycemic drugs, anti-inflammatory drugs or statins)
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>40 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Hospital das Clinicas de Ribeirao Preto, Departamento Ginecologia e Obstetricia</name>
      <address>
        <city>Ribeirao Preto</city>
        <state>SP</state>
        <zip>14049900</zip>
        <country>Brazil</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Brazil</country>
  </location_countries>
  <verification_date>July 2009</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>March 22, 2011</study_first_submitted>
  <study_first_submitted_qc>March 22, 2011</study_first_submitted_qc>
  <study_first_posted type="Estimate">March 23, 2011</study_first_posted>
  <last_update_submitted>April 1, 2011</last_update_submitted>
  <last_update_submitted_qc>April 1, 2011</last_update_submitted_qc>
  <last_update_posted type="Estimate">April 4, 2011</last_update_posted>
  <responsible_party>
    <name_title>Rui Alberto Ferriani</name_title>
    <organization>University of Sao Paulo</organization>
  </responsible_party>
  <keyword>obesity</keyword>
  <keyword>contraceptives hormonal</keyword>
  <keyword>levonorgestrel-releasing intrauterine device</keyword>
  <keyword>cardiovascular risk</keyword>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Levonorgestrel</mesh_term>
    <mesh_term>Hemostatics</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

